The Cigna Group's (CI) "Buy" Rating Reaffirmed at Guggenheim

The Cigna Group (NYSE:CI - Get Free Report)'s stock had its "buy" rating reaffirmed by equities researchers at Guggenheim in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $388.00 target price on the health services provider's stock. Guggenheim's price objective suggests a potential upside of 22.64% from the stock's current price.

Several other research firms have also weighed in on CI. Sanford C. Bernstein lowered shares of The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 price objective on the stock. in a research note on Thursday, February 6th. Truist Financial upped their target price on The Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a report on Monday, May 12th. Morgan Stanley raised their price target on The Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Robert W. Baird reduced their price objective on The Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Finally, Wall Street Zen upgraded The Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $379.33.

The Cigna Group Stock Up 1.2%

NYSE CI traded up $3.68 during trading hours on Friday, reaching $316.36. 1,667,838 shares of the company traded hands, compared to its average volume of 1,716,406. The stock has a market capitalization of $84.51 billion, a PE ratio of 25.85, a PEG ratio of 0.98 and a beta of 0.47. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a 50 day moving average of $325.35 and a two-hundred day moving average of $309.95.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping the consensus estimate of $6.35 by $0.39. The business had revenue of $65.45 billion for the quarter, compared to analysts' expectations of $60.39 billion. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The company's quarterly revenue was up 14.4% compared to the same quarter last year. During the same quarter last year, the company posted $6.47 earnings per share. As a group, equities analysts expect that The Cigna Group will post 29.77 earnings per share for the current year.

Insider Activity at The Cigna Group

In other news, Director Elder Granger sold 2,376 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the transaction, the director now owns 5,471 shares in the company, valued at approximately $1,697,924.85. This trade represents a 30.28% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Nicole S. Jones sold 4,904 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the completion of the sale, the insider now owns 29,421 shares in the company, valued at $9,065,198.52. The trade was a 14.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,751 shares of company stock worth $13,603,991 over the last quarter. 0.70% of the stock is currently owned by company insiders.

Institutional Trading of The Cigna Group

A number of large investors have recently added to or reduced their stakes in the business. TCTC Holdings LLC acquired a new stake in shares of The Cigna Group during the 4th quarter valued at $25,000. Flaharty Asset Management LLC acquired a new stake in shares of The Cigna Group during the first quarter worth $28,000. 1248 Management LLC purchased a new stake in shares of The Cigna Group during the first quarter valued at $29,000. Activest Wealth Management boosted its position in shares of The Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares during the period. Finally, Collier Financial acquired a new position in shares of The Cigna Group in the 4th quarter valued at $32,000. 86.99% of the stock is currently owned by institutional investors.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.